secwatch.observer — SEC 8-K summary
======================================

Issuer:     GE HealthCare Technologies Inc. (GEHC)
CIK:        0001932393
Form:       8-K
Filed at:   2023-07-25T23:59:59+00:00
Accession:  0001932393-23-000111
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GE HealthCare Q2 revenues up 9% organically; raises FY2023 guidance
-------------------------------------------------------------------

- Revenue $4.8B, +7% reported, +9% organic; organic orders +6%.
- Net income $418M ($0.91 EPS) vs $485M ($1.04) prior year; adjusted EPS $0.92 vs $1.15.
- Imaging revenue +9% organic to $2.6B; Pharmaceutical Diagnostics +20% organic to $568M.
- FY2023 guidance raised: organic revenue growth 6-8% (prior 5-7%); adjusted EPS $3.70-$3.85 (prior $3.60-$3.75).
- Adjusted EBIT margin guidance 15.0%-15.5%, free cash flow conversion 85%+.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1932393/000193239323000111/0001932393-23-000111-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1932393/000193239323000111/gehc-20230725.htm
  HTML page:      https://secwatch.observer/filing/0001932393-23-000111

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer